Added to YB: 2024-07-10
Pitch date: 2024-07-10
ACST [bullish]
Grace Therapeutics, Inc.
+6.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
Market Cap
$46.0M
Pitch Price
$3.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.76
P/E
-3.92
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
ACASTI PHARMA INC ACST
A summary for this pitch has not been created yet.
Read full article (0 min)